Stocklytics Platform
Asset logo for symbol PTGX
Protagonist Therapeutics
PTGX81
$45.63arrow_drop_down0.93%-$0.42
Asset logo for symbol PTGX
PTGX81

$45.63

arrow_drop_down0.93%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Protagonist Therapeutics (PTGX) Stocklytics Forecast

Protagonist Therapeutics Inc (PTGX) is a biopharmaceutical company focused on the development and commercialization of novel peptide-based therapeutics for the treatment of gastrointestinal diseases. With its innovative approach and cutting-edge technology, the company has attracted significant attention from investors and analysts alike. As such, analysts have provided several price targets for PTGX stock, giving investors an insight into the future potential of the company.
According to analysts, the average price target for PTGX stock by 2023 is $25, representing a substantial upside potential from its current price. This reflects the optimism surrounding Protagonist Therapeutics' pipeline of drug candidates and their potential to address unmet medical needs. Analysts believe that PTGX has a strong chance of success, given its differentiated approach and the positive results observed in early-stage clinical trials.
add Protagonist Therapeutics to watchlist

Keep an eye on Protagonist Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Protagonist Therapeutics (PTGX) stock?

Analysts have set a target price of $38.93 for Protagonist Therapeutics (PTGX), based on forecasts from 27 analysts. The predicted price range extends from a high of $70 to a low of $21. This represents a potential increase of up to 53.38% and a decrease of -53.98% from the current price of $45.64. These forecasts are as of 2021 Oct 12.
help

What are the analyst ratings for Protagonist Therapeutics (PTGX) stock?

Currently, there are no analyst ratings available for Protagonist Therapeutics (PTGX), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Protagonist Therapeutics (PTGX) stock?

At present, there is no AI or machine-learning-based price prediction available for Protagonist Therapeutics (PTGX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level